NIH-funded research U01 cooperative agreement

Keeping the brain better oxygenated after severe head injury

Official title: Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3)

Funded at University of Michigan at Ann Arbor · NIH-11471592 · Data updated 2026-11-12

This trial compares using a small brain oxygen sensor plus targeted treatments to standard ICU care for people with severe traumatic brain injury to reduce low brain oxygen and help recovery.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJuly 1, 2018
Project endFebruary 28, 2029
Funding year2026
Award (this year)$75,000
NIH project number3U01NS099046-06S2
Project IDNIH-11471592 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with severe traumatic brain injury (prolonged traumatic coma) who require ICU care and invasive brain monitoring soon after injury.

Less likely to help

Patients with mild head injuries, those who are not eligible for invasive brain monitoring, or those too unstable for the procedure are unlikely to benefit from this protocol.

What this research studies

If you or a loved one has a severe traumatic brain injury and is in the ICU, doctors would place a small sensor to measure oxygen in the brain and follow a treatment plan when oxygen is low. Patients are randomly assigned to receive brain-oxygen-guided care in addition to standard intracranial pressure monitoring or to receive standard care alone. The team will use specific steps to raise brain oxygen when the sensor indicates hypoxia and will track safety and functional recovery over time. This Phase 3 randomized trial builds on earlier BOOST work that showed large reductions in brain hypoxia when care was guided by the oxygen sensor.

Why it matters

Potential benefit: If successful, this approach could reduce dangerous low-oxygen episodes in the brain and improve long-term functional recovery after severe TBI.

How similar studies have gone: A prior Phase 2 BOOST trial reduced brain hypoxia by 74% and showed a trend toward better outcomes, but BOOST-3 is designed to confirm whether clinical recovery is improved.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Silbergleit, Robert — University of Michigan at Ann Arbor
  • Study coordinator: Silbergleit, Robert

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.